2023 annual financial data
BioNexus Gene Lab 2023 Operating margin
BioNexus Gene Lab 2023 operating margin with verified reported values.
Direct answer
Operating margin was -26.54%.
Operating income was -2,593,588 USD and net income was -2,629,043 USD.
Operating cash flow was -1,760,803 USD.
Get free BioNexus Gene Lab email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 9,770,806 USD
- Operating income
- -2,593,588 USD
- Net income
- -2,629,043 USD
- Operating cash flow
- -1,760,803 USD